AstraZeneca To Expand Savings Programs For US Inhaled Respiratory Portfolio

(RTTNews) - AstraZeneca (AZN.L, AZN) said it will expand the savings programs for entire US inhaled respiratory portfolio. The company said, starting June 1, 2024, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines, includin https://www.nasdaq.com/articles/astrazeneca-to-expand-savings-programs-for-us-inhaled-respiratory-portfolio